Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Mineralys Therapeutics (NASDAQ: MLYS)
Follow
NASDAQ:MLYS
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/14/2025
Buy
$1.08
6,348
$7K
123,052
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/14/2025
Sell
$13.69
2,966
$41K
120,086
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/14/2025
Sell
$14.83
8,400
$125K
111,686
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/14/2025
Sell
$1.08
6,348
$7K
107,926
NASDAQ
MLYS
Mineralys Therapeutics
Levy Adam Scott
/
officer: CFO and Secretary
04/11/2025
Sell
$12.06
10,757
$130K
215,340
NASDAQ
MLYS
Mineralys Therapeutics
Congleton Jon
/
director, officer: Chief Executive Officer
04/11/2025
Sell
$12.19
15,319
$187K
862,289
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/01/2025
Buy
$1.08
1,606
$2K
172,475
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/01/2025
Sell
$15.00
30,574
$459K
141,901
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/01/2025
Sell
$16.02
2,791
$45K
139,110
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/01/2025
Sell
$16.77
22,406
$376K
116,704
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
04/01/2025
Sell
$1.08
1,606
$2K
114,274
NASDAQ
MLYS
Mineralys Therapeutics
Samsara BioCapital GP, LLC
/
10 percent owner
03/13/2025
Buy
$13.50
600,000
$8.100M
5.67M
NASDAQ
MLYS
Mineralys Therapeutics
AKKARAJU SRINIVAS
/
director
03/13/2025
Buy
$13.50
600,000
$8.100M
5.67M
NASDAQ
MLYS
Mineralys Therapeutics
RA CAPITAL MANAGEMENT, L.P.
/
director
03/13/2025
Buy
$13.50
1.30M
$17.500M
4.28M
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
03/12/2025
Buy
$1.08
6,349
$7K
170,869
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
03/12/2025
Sell
$1.08
6,349
$7K
115,880
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.